Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis (NCFB): A systematic review and meta-analysis

被引：0
|
作者：
Nakagawa, Natsuki [1 ]
Ito, Masashi [2 ]
Asakura, Takanori [3 ]
机构：
[1] Univ Tokyo Hosp, Dept Resp Med, Tokyo, Japan
[2] Japan AntiTB Assoc, Fukujuji Hosp, Resp Dis Ctr, Tokyo, Japan
[3] Kitasato Univ, Sch Pharm, Lab Bioregulatory Med, Dept Clin Med, Tokyo, Japan
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP11-002
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [41] Clinical Efficacy and Safety of Budesonide-Formoterol in Non-Cystic Fibrosis Bronchiectasis
    Angel Martinez-Garcia, Miguel
    Soler-Cataluna, Juan J.
    Catalan-Serra, Pablo
    Roman-Sanchez, Pilar
    Perpina Tordera, Miguel
    CHEST, 2012, 141 (02) : 461 - 468
  • [42] ASSOCIATION OF CHRONIC MACROLIDE THERAPY ON THE ACQUISITION OF PSEUDOMONAS AERUGINOSA IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS
    Shah, Tejas E.
    Metersky, Mark L.
    Brunton, Amanda E.
    Choate, Radmila
    Dimango, Angela M.
    Johnson, Margaret M.
    Lapinel, Nicole C.
    Restrepo, Marcos I.
    CHEST, 2022, 162 (04) : 1935A - 1935A
  • [43] Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis
    Zhou, Yunchun
    Mu, Wei
    Zhang, Jihua
    Wen, Shi Wu
    Pakhale, Smita
    BMJ OPEN, 2022, 12 (08):
  • [44] Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety
    Noble, Meredith
    Tregear, Stephen J.
    Treadwell, Jonathan R.
    Schoelles, Karen
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2008, 35 (02) : 214 - 228
  • [45] Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis
    Tarrant, Benjamin J.
    Le Maitre, Caitlin
    Romero, Lorena
    Steward, Ranjana
    Button, Brenda M.
    Thompson, Bruce R.
    Holland, Anne E.
    RESPIROLOGY, 2017, 22 (06) : 1084 - 1092
  • [46] SELF-MANAGEMENT FOR NON-CYSTIC FIBROSIS BRONCHIECTASIS: COCHRANE SYSTEMATIC REVIEW
    Kelly, C.
    Spencer, S.
    Grundy, S.
    Lynes, D.
    Evans, D. J. W.
    Guder, S.
    Milan, S. J.
    THORAX, 2017, 72 : A114 - A115
  • [47] Safety profile of drugs used in non-cystic fibrosis bronchiectasis: a narrative review
    Upadhyay, Henil
    Aliberti, Stefano
    Husband, Andrew
    Chalmers, James D.
    Hester, Katy
    De Soyza, Anthony
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2024, 15
  • [48] Long-term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: A systematic review and meta-analysis
    Cesareo, Roberto
    Tabacco, Gaia
    Naciu, Anda Mihaela
    Crescenzi, Anna
    Bernardi, Stella
    Romanelli, Francesco
    Deandrea, Maurilio
    Trimboli, Pierpaolo
    Palermo, Andrea
    Castellana, Marco
    CLINICAL ENDOCRINOLOGY, 2022, 96 (02) : 97 - 106
  • [49] The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis
    Nicolson, Caroline H. H.
    Stirling, Robert G.
    Borg, Brigitte M.
    Button, Brenda M.
    Wilson, John W.
    Holland, Anne E.
    RESPIRATORY MEDICINE, 2012, 106 (05) : 661 - 667
  • [50] Inaccurate data in my meta-analysis of prolonged macrolides for patients with non-cystic fibrosis bronchiectasis in adult
    Zhuo, Guang-Ying
    He, Qing
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 29 (01) : 90 - 90
12345